Staar Surgical Co. said it received U.S. government approval to begin trials on people of its implantable contact lenses, the only device of its kind. The Food and Drug Administration ruled that the company can implant 10 of the lenses in patients at four eye clinics, the Monrovia-based medical products maker said. Staar Surgical’s lenses are implanted in the eye behind the iris and in front of the natural lens, the company said. Staar Surgical shares rose 50 cents to close at $13.375 on Nasdaq.
Staar Wins OK for Lens-Implant Trials
Times Staff and Wire Reports